. Author manuscript; available in PMC: 2010 Apr 5.

Published in final edited form as: ASAIO J. 2008 Nov–Dec;54(6):578–584. doi: 10.1097/MAT.0b013e318186891f

Table 1.

The DCF Model Produced a Significant Reduction in Cardiac Output (CO) While Left Atrial Pressure (LAP) More Than Double

	HR (bpm)	SV (ml)	CO (L/min)	LVPpksys (mm Hg)	MAP (mm Hg)	LAP (mm Hg)	LVPed (mm Hg)
Normal	90 ± 5	118 ± 10	10.3 ± 0.5	116 ± 3	91 ± 4	5 ± 2	6 ± 2
DCF	77 ± 3^*	110 ± 7	8.5 ± 0.6^*	106 ± 3^*	81 ± 3^*	11 ± 2^*	14 ± 3^*

Values are given as mean ± SD.

Normal vs. DCF (p < 0.05).

HR, heart rate; SV, stroke volume; LVPpksys, left ventricular peak systolic pressure; MAP, mean aortic pressure; LAP, left atrial pressure; LVPed, left ventricular end diastolic pressure at normal (before oral dose of Monensin); DCF, diminished cardiac function.